Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-3-8
pubmed:abstractText
Concentrations of N-terminal pro brain natriuretic peptide (NT-proBNP) increase in patients with heart failure and other cardiovascular (CV) diseases and are strong prognostic markers. In patients with end-stage renal disease (ESRD) in hemodialysis (HD), levels of NT-proBNP are almost always raised. In ESRD patients undergoing HD, we aimed at (i) identifying the factors that affect levels of NT-proBNP, (ii) determining the effect of HD on NT-proBNP, and (iii) determining the prognostic impact of NT-proBNP. A total of 109 patients underwent physical examination, electrocardiogram, and echocardiography. Serum NT-proBNP was measured before and after HD (Elecsys 2010). NT-proBNP levels were markedly elevated (pre-HD 4079 pg/ml, post-HD 2759 pg/ml, P<0.001). There was a strong inverse correlation between NT-proBNP and left ventricular ejection fraction (LVEF) (P=0.043), 24-h urine production (P=0.006), and K(t)/V (efficacy of dialysis) (P=0.016) and a positive correlation with left ventricular hypertrophy (LVH) (P=0.014). Patients with higher concentrations, both pre- and post-HD had an increased mortality rate compared to those with lower concentrations (P=0.007, P=0.002). We found age (P=0.009) and NT-proBNP (pre-HD P=0.007, post-HD P=0.001) predictive of death. Our findings demonstrate that CV disease in terms of LVH and reduced LVEF in addition to 24-h urine production and K(t)/V determine NT-proBNP levels. Post-HD levels of NT-proBNP were lower than pre-HD levels; both predictive of mortality.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0085-2538
pubmed:author
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
548-54
pubmed:meshHeading
pubmed-meshheading:17299526-Adult, pubmed-meshheading:17299526-Aged, pubmed-meshheading:17299526-Aged, 80 and over, pubmed-meshheading:17299526-Biological Markers, pubmed-meshheading:17299526-Cardiovascular Diseases, pubmed-meshheading:17299526-Female, pubmed-meshheading:17299526-Humans, pubmed-meshheading:17299526-Kidney Failure, Chronic, pubmed-meshheading:17299526-Male, pubmed-meshheading:17299526-Middle Aged, pubmed-meshheading:17299526-Natriuretic Peptide, Brain, pubmed-meshheading:17299526-Peptide Fragments, pubmed-meshheading:17299526-Predictive Value of Tests, pubmed-meshheading:17299526-Prognosis, pubmed-meshheading:17299526-Regression Analysis, pubmed-meshheading:17299526-Renal Dialysis, pubmed-meshheading:17299526-Risk Factors, pubmed-meshheading:17299526-Stroke Volume, pubmed-meshheading:17299526-Ventricular Dysfunction, Left
pubmed:year
2007
pubmed:articleTitle
N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
pubmed:affiliation
Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Copenhagen, Denmark. lhm@dadlnet.dk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't